International Conference on Malignant Lymphoma
18th International Conference on Malignant Lymphoma (June 17-21, 2025 - Lugano, Switzerland)
#18ICML
www.icml.ch
@elizahawkes.bsky.social
Chief Clinical Research Officer & Lymphoma Clinical Innovations Lab head At Olivia Newton John Cancer Research Institute. Lymphoma Lead At ONJCancerCentre Lymphoma Researcher Monash University #lymsm #hemesky #medsky Views are my own
@broeckelmann.bsky.social
Physician Scientist in Cologne, interested in Hemato-Oncology, Lymphoma & Immunotherapy. Views are mine & no advise, repost/like no endorsement. COI: http://bit.ly/34MaLOt
@fgbonadonna.bsky.social
FGB promotes therapeutic innovation from the earliest phases of research and the education of new generations of physician-scientists in Oncology
@cp-trendscancer.bsky.social
Trends in Cancer is a leading reviews journal covering advances in cancer research and oncology published by Cell Press. Tweets by Editor Danielle Loughlin.
@jessicaokosun.bsky.social
Professor & Physician Scientist @qmbci.bsky.social. Lymphoma specialist @ Barts Health. Our lab research interests: cancer heterogeneity, somatic evolution, biomarkers, multi-omics, translational lymphoma research
@ascocancer.bsky.social
Account of the American Society of Clinical Oncology & its affiliate the Association for Clinical Oncology. The world’s leading professional organization representing more than 50,000 oncology professionals caring for people with cancer.
@helloeacr.bsky.social
The European Association for Cancer Research has 14,000+ members. Our aim? Advancing cancer research 🥼🔬🌍 #KeepResearchCurious www.eacr.org
@myesmo.bsky.social
The European Society for Medical Oncology (ESMO) is a reference organisation for cancer education and information, supporting the oncology community’s work.
@calcinottolab.bsky.social
We pioneer next-generation immunotherapy by blocking pro-tumoral immune activity. Our research uncovers how tumor cells, microbiota, and immune infiltrates drive hormone-dependent and BRCA-mutated cancers. https://ior.usi.ch/group/cancer-immunotherapy
@frbertoni.bsky.social
Institute of Oncology Research. President, ICML Local Organizing Committee. USI. Personal opinions only. #lymsm #lymphoma
@pwmjohnson.bsky.social
Oncologist and lymphoma specialist. National Clinical Director for cancer at NHSE. Chair, Cancer Goal, Office for Life Sciences. University of Southampton.
@johnpleonardmd.bsky.social
Doctor for lymphoma patients, researcher, collaborator, professor/senior associate dean @WeillCornell & @NYPhospital Tweets mine RT not=endorsement, he/him/his
@vjhemonc.bsky.social
The Video Journal of Hematology & Hematological Oncology is dedicated to providing up-to-date information & international expertise🩸🎥 🗞️ #Leusm #Lymsm #MMSM #MDSsm #MPNsm #BMTsm #CTSM #ImmunoOnc #CLLsm #AMLsm #Leukemia #Lymphoma #Myeloma
@sabcs.bsky.social
SABCS is the world's largest gathering of doctors, researchers and scientists sharing state-of-the-art information on experimental biology, etiology, prevention, diagnosis, and therapy for breast cancer and premalignant breast diseases. www.sabcs.org
@apccc.bsky.social
APCCC facilitates discussions and debates on advanced prostate cancer diagnostic and treatment options.
@womeninlymphoma.bsky.social
Global alliance promoting leadership of female lymphoma clinicians researchers educators via advocacy networking education www.womeninlymphoma.org Supported by www.lymphoma.org.au X @womeninlymphoma
@cwynkate2.bsky.social
Lymphoma & partic CNSL, TCL & immunodeficiency UCLH/UCL (no medical advice) views my own
@theaacr.bsky.social
The mission of the American Association for Cancer Research (AACR) is to prevent and cure cancer through research, education, communication, collaboration, science policy and advocacy, and funding for cancer research.
@dochutchings.bsky.social
Haemato-oncologist. Clinical researcher. Mostly lymphoma and phase 1 haematology studies.
@lymphomadoc.bsky.social
Professor @mdanderson.bsky.social , Lead of Lymphoma/Myeloma Service Line, Director of Clinical Research, Section Chief of Aggressive/Indolent Lymphomas, Opinions mine
@ukons.bsky.social
@oncologynurseadv.bsky.social
OncologyNurseAdvisor.com offers clinical updates and evidence-based guidance to the oncology nurse community and includes regular coverage of a variety of topics.
@lymphomaaction.bsky.social
We're the UK’s only charity dedicated to lymphoma - the most common blood cancer. We're here to inform, support and connect. Find out more: https://lymphoma-action.org.uk/
@hemasphere-journal.bsky.social
The official open access journal of EHA - we publish basic, translational, & clinical heme research. Ranked #7 of heme journals; 2023 Impact Factor = 11.9. #hematology #ScientificPublishing #BloodSky #HemeSky 👓 hemaspherejournal.com
@ariannabaggiolini.bsky.social
Stem cell and cancer biologist | Hofschneider Professor and Group Leader at the Institute of Oncology Research (IOR), Switzerland www.baggiolinilab.org
@usi.ch
Official profile of Università della Svizzera italiana (USI). News and event from our campuses and beyond. Profilo ufficiale dell'Università della Svizzera italiana (USI). Notizie ed eventi dai nostri campus e oltre.
@iorbellinzona.bsky.social
8 Research groups 120+ Staff members 700+ Issued publications 60+ Awarded PhD degrees www.ior.usi.ch Based in Bellinzona (Switzerland), IOR is affiliated to @usi.ch and member of Bios+ (www.biosplus.ch).
@bsky.app
official Bluesky account (check username👆) Bugs, feature requests, feedback: support@bsky.app